Ellen Heber-Katz

From Wikipedia, the free encyclopedia
Ellen Heber-Katz
Born
Philadelphia, Pennsylvania, U.S
Alma materUniversity of Pennsylvania
University of Wisconsin Madison
Scientific career
FieldsImmunology, Microbiology
InstitutionsLankenau Institute for Medical Research
The Wistar Institute

Ellen Heber-Katz is an American immunologist and regeneration biologist who is a professor at Lankenau Institute for Medical Research (LIMR).[1] She discovered that the Murphy Roths Large (MRL) mouse strain can regenerate wounds without scarring and can fully restore damaged tissues.[2][3][4][5][6] Her work on regeneration has been extended into National Cancer Institute (NCI)-funded studies of novel aspects of breast cancer causation.[7] Her research interests include immunology, regenerative medicine, and cancer.[8]

Education and career[edit]

Heber-Katz received her B.A. in microbiology and immunology in 1969, and her M.S. in immunology in 1972 from the University of Wisconsin-Madison, studying with Robert E. Click.[9] Her M.S. thesis focused on the role of reducing agents as critical factors in cellular immune responses.[9] In 1976, she earned her Ph.D. in immunology from the University of Pennsylvania, studying with D.B. Wilson.[10]

In her thesis work, she showed that single T-cell subsets could respond to both histocompatibility antigens and environmental antigens, establishing the unity of these two branches of the immune response. She pursued postdoctoral studies at the National Institutes of Allergy and Infectious Diseases (NIAID) in the Laboratory of Immunology, under the immunologists E. Shevach, W.E. Paul, and R. Schwartz. While there, she established the first functional evidence for the formation of a molecular complex between a T-cell antigen and the MHC class Ia molecule, anticipating the crystal structure later determined for this fundamental molecular complex in T-cell biology.[11][12]

At NIAID, Heber-Katz also conducted experiments that illuminated the molecular details involved in controlling interactions between T-cells and macrophages.[13] The experiment termed the "A/5R experiment" confirmed the Determinant Selection Hypothesis, which concerned the spatial relationships between the histocompatibility I-A and I-E molecules on the surface of antigen-presenting cells, the bound antigen and the recognition structure of the T-cell receptor, contributing to the fundamental understanding of how ‘foreign’ antigens activate the adaptive immune system in mammals.[14]

In 1976, Heber-Katz was appointed as the Assistant Professor at the Wistar Institute. In her viral studies, she developed a T-cell vaccine for the herpes virus HSV-2 that could protect subjects against lethal infection in the total absence of an antibody response, proving for the first time that, by themselves, T-cells could protect against lethal viral infection.[15] In her autoimmune studies, she developed the “V Region Disease Hypothesis” in showing that the same T-cell receptor in mice and rats recognized different antigens to mediate different diseases.[16]

In 1995, during her investigations into how autoimmune disease arises, Heber-Katz discovered that two of the mouse strains she was using (MRL/LPR and MRL/MPJ) had an unusual ability to heal in a regenerative amphibian-like fashion rather than through a fibrotic response.[17][18] This was shown first for ear hole closure but was extended to many organ systems such as the heart. Together with Dr. Robert K. Naviaux at the University of California at San Diego, an expert in mitochondrial physiology, Heber-Katz discovered that a key to non-scarring healing in the adult MRL mouse was activation of an embryonic metabolic pattern known as aerobic glycolysis, suggesting the types of molecules involved in this unusual healing response.[19] In particular, hypoxia-inducible factor-1a (HIF-1a) was identified as a critical molecule, based on the discovery that blocking its activity in MRL mice was sufficient to eliminate the regenerative response.[20]

She has investigated therapeutic strategies to activate this regenerative healing response with Phillip Messersmith, a biomaterials chemist at the University of California at Berkeley.[20][21] An initial milestone was the creation of time-release hydrogel formulations of a prolyl hydroxylase inhibitor that, when delivered subdermally, confers regenerative healing to a normal mouse. She has obtained evidence of regenerative healing of chronic wounds and osteoporosis in aged mice using this experimental therapeutic approach.[22] With Dr. George Hajishengallis at the University of Pennsylvania School of Dentistry, the hydrogel drug formulation was shown to induce rapid and complete bone and soft tissue regrowth in a preclinical model of periodontal disease, characterized by tooth loss and jaw bone degeneration.[23]

References[edit]

  1. ^ "Ellen Heber-Katz, PhD - LIMR - Researcher Profile". LIMR. Retrieved 2016-04-02.
  2. ^ Galatz, Leesa M.; Gerstenfeld, Louis; Heber-Katz, Ellen; Rodeo, Scott A. (2015). "Tendon regeneration and scar formation: The concept of scarless healing". Journal of Orthopaedic Research. 33 (6): 823–831. doi:10.1002/jor.22853. PMC 6084432. PMID 25676657.
  3. ^ Zhang, Yong (2015-06-03). "Drug-induced regeneration in adult mice | Science Translational Medicine". Science Translational Medicine. 7 (290): 290ra92. doi:10.1126/scitranslmed.3010228. PMC 4687906. PMID 26041709.
  4. ^ Gourevitch, D; Kossenkov, AV; Zhang, Y; Clark, L; Chang, C; Showe, LC; Heber-Katz, E (2015-09-28). "Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective". Adv Wound Care (New Rochelle). 3 (9): 592–603. doi:10.1089/wound.2014.0528. PMC 4152783. PMID 25207202.
  5. ^ Edwards, RG (2015-09-28). "From embryonic stem cells to blastema and MRL mice". Reprod. Biomed. Online. 16 (3): 425–61. doi:10.1016/S1472-6483(10)60605-0. PMID 18339268.
  6. ^ "Case Closed: A Fluky Finding Raises Hopes for Mending Wounds". Scientific American. Retrieved 2016-04-02.
  7. ^ Nathan A. Berger (July 2015). Murine Models, Energy Balance, and Cancer: 9783319167329: Medicine & Health Science Books @. Springer. ISBN 978-3319167329.
  8. ^ "From Immunity and Vaccines to Mammalian Regeneration". The Journal of Infectious Diseases. 212. 2015. Retrieved 2016-04-03.[dead link]
  9. ^ a b Click, Robert E. (2014). "A review: alteration of in vitro reproduction processes by thiols -emphasis on 2-mercaptoethanol". The Journal of Reproduction and Development. 60 (6): 399–405. doi:10.1262/jrd.2014-055. ISSN 1348-4400. PMC 4284312. PMID 25087867.
  10. ^ Wilson, DB; Heber-Katz, E; Sprent, J; Howard, JC (1977). "On the possibility of multiple t-cell receptors". Cold Spring Harb Symp Quant Biol. 41 (2): 559–561. doi:10.1101/sqb.1977.041.01.064. PMID 70304.
  11. ^ Germain, Ronald N. (2015-12-15). "William E. Paul, M.D. (1936-2015), President, The American Association of Immunologists, 1986-1987". Journal of Immunology. 195 (12): 5519–5521. doi:10.4049/jimmunol.1590025. ISSN 1550-6606. PMID 26637660. S2CID 12062111.
  12. ^ Heber-Katz, E; Schwartz, RH; Matis, LA; Fairwell, T; Appella, E; Hansburg, D (1982). "Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation". J Exp Med. 155 (4): 1086–1099. doi:10.1084/jem.155.4.1086. PMC 2186641. PMID 6174670.
  13. ^ Heber-Katz, E.; Hansburg, D.; Schwartz, R. H. (1983). "The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation". The Journal of Molecular and Cellular Immunology: JMCI. 1 (1): 3–18. ISSN 0724-6803. PMID 6101061.
  14. ^ Heber-Katz, E; Schwartz, RH (1983). The effect of antigen and Ia molecule interaction on immune response gene control, Ir Genes: Past, Present, and Future. Clifton, NJ: Humana Press. p. 295.
  15. ^ Heber-Katz, Ellen (2015-07-15). "From Immunity and Vaccines to Mammalian Regeneration". The Journal of Infectious Diseases. 212 (Suppl 1): S52–58. doi:10.1093/infdis/jiu637. ISSN 1537-6613. PMC 4574550. PMID 26116734.
  16. ^ Heber-Katz, E.; Acha-Orbea, H. (May 1989). "The V-region disease hypothesis: evidence from autoimmune encephalomyelitis". Immunology Today. 10 (5): 164–169. doi:10.1016/0167-5699(89)90174-6. ISSN 0167-5699. PMID 2663017.
  17. ^ Clark, LD; Clark, RK; Heber-Katz, E (1998). "A new murine model for mammalian wound repair and regeneration". Clinical Immunology and Immunopathology. 88 (1): 33–45. doi:10.1006/clin.1998.4519. PMID 9683548.
  18. ^ Gourevitch, Dmitri; Kossenkov, Andrew V.; Zhang, Yong; Clark, Lise; Chang, Celia; Showe, Louise C.; Heber-Katz, Ellen (2014-09-01). "Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective". Advances in Wound Care. 3 (9): 592–603. doi:10.1089/wound.2014.0528. ISSN 2162-1918. PMC 4152783. PMID 25207202.
  19. ^ Naviaux, Robert K.; Le, Thuy P.; Bedelbaeva, Khamilia; Leferovich, John; Gourevitch, Dmitri; Sachadyn, Pawel; Zhang, Xiang-Ming; Clark, Lise; Heber-Katz, Ellen (March 2009). "Retained features of embryonic metabolism in the adult MRL mouse". Molecular Genetics and Metabolism. 96 (3): 133–144. doi:10.1016/j.ymgme.2008.11.164. ISSN 1096-7206. PMC 3646557. PMID 19131261.
  20. ^ a b Zhang, Y; Bedelbaeva, K; Strehin, I; Gourevitch, D; Messersmith, PB; Heber-Katz, E (2015). "Drug-induced Regeneration in Adult Mice". Science Transl Med. 7 (290): 212–221. doi:10.1016/j.msec.2015.04.018. PMID 26042709.
  21. ^ Heber-Katz, Ellen; Messersmith, Phillip. "Regenerative wound healing via inflammation-modulating biomaterials". {{cite journal}}: Cite journal requires |journal= (help)
  22. ^ Rai, Muhammad Farooq; Hashimoto, Shingo; Johnson, Eric E.; Janiszak, Kara L.; Fitzgerald, Jamie; Heber-Katz, Ellen; Cheverud, James M.; Sandell, Linda J. (July 2012). "Heritability of articular cartilage regeneration and its association with ear wound healing in mice". Arthritis and Rheumatism. 64 (7): 2300–2310. doi:10.1002/art.34396. ISSN 1529-0131. PMC 3360138. PMID 22275233.
  23. ^ Nagai, K; Ideguchi, H; Kajikawa, T; Li, X; Chavakis, T; Cheng, J; Messersmith, PB; Heber-Katz, E; Hajishengallis, G (2020). "An injectable hydrogel-formulated inhibitor of prolyl-4-hydroxylase promotes T regulatory cell recruitment and enhances alveolar bone regeneration during resolution of experimental periodontitis". FASEB Journal. 34 (10): 13726–13740. doi:10.1096/fj.202001248R. PMC 7722135. PMID 32812255. S2CID 221180276.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Ellen_Heber-Katz&oldid=1220242198"